Holen Sie sich die Stockscreener-App
26.11
9.84%
-2.85
Handel nachbörslich:
25.80
-0.31
-1.19%
Schlusskurs vom Vortag:
$28.96
Offen:
$29.21
24-Stunden-Volumen:
1.02M
Relative Volume:
1.37
Marktkapitalisierung:
$742.24M
Einnahmen:
$30.43M
Nettoeinkommen (Verlust:
$-18.15M
KGV:
-37.84
EPS:
-0.69
Netto-Cashflow:
$-9.08M
1W Leistung:
-4.64%
1M Leistung:
+147.96%
6M Leistung:
+134.17%
1J Leistung:
+129.24%
1-Tages-Spanne:
$26.01
$29.35
1-Wochen-Bereich:
$24.21
$30.10
52-Wochen-Spanne:
$9.76
$30.10
Clearpoint Neuro Inc Stock (CLPT) Company Profile
Firmenname
Clearpoint Neuro Inc
Sektor
Branche
Telefon
(949) 900-6833
Adresse
120 S. SIERRA AVENUE, SOLANA BEACH, CA
Vergleichen Sie CLPT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLPT
Clearpoint Neuro Inc
|
26.11 | 823.26M | 30.43M | -18.15M | -9.08M | -0.69 |
|
ABT
Abbott Laboratories
|
132.57 | 232.02B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.41 | 144.14B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.60 | 141.53B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.45 | 123.78B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.94 | 44.14B | 5.69B | 1.41B | 577.90M | 6.9828 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-25 | Fortgesetzt | B. Riley Securities | Buy |
| 2023-10-24 | Eingeleitet | Stifel | Buy |
| 2023-02-16 | Fortgesetzt | B. Riley Securities | Buy |
| 2022-04-05 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-03-18 | Eingeleitet | Lake Street | Buy |
| 2020-07-17 | Eingeleitet | B. Riley FBR | Buy |
Alle ansehen
Clearpoint Neuro Inc Aktie (CLPT) Neueste Nachrichten
ClearPoint Neuro (NASDAQ:CLPT) Sets New 1-Year HighTime to Buy? - MarketBeat
What’s next for ClearPoint Neuro Inc. stock priceEarnings Performance Report & Precise Swing Trade Entry Alerts - newser.com
Combining machine learning predictions for ClearPoint Neuro Inc.July 2025 PostEarnings & Reliable Price Breakout Alerts - newser.com
ClearPoint Neuro's (CLPT) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
ClearPoint Neuro (NASDAQ:CLPT) Trading Up 7.4%Should You Buy? - MarketBeat
ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be presented at the CNS Annual Meeting in Los Angeles - MarketScreener
ClearPoint Neuro reports positive results from brain tumor laser therapy study - Investing.com
ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles - Stock Titan
ClearPoint Neuro expands regulatory approvals to 34 countries By Investing.com - Investing.com Nigeria
ClearPoint Neuro expands regulatory approvals to 34 countries - Investing.com India
ClearPoint Neuro Announces Expanded International Clearances for Key Therapy Delivery Product; Now Totaling 34 Countries Worldwide - ACCESS Newswire
34 Countries: ClearPoint Neuro Expands Regulatory Clearances with Canada, Hong Kong and Taiwan additions - Stock Titan
Clearpoint Neuro Reaches New 52-Week High of $28.80, Up 377% - Markets Mojo
CLPT Expands Into Robotic System Supporting Cell and Gene Therapies - The Globe and Mail
Will ClearPoint Neuro Inc. stock benefit from automationJuly 2025 Macro Moves & Reliable Price Breakout Signals - newser.com
Using RSI to spot recovery in ClearPoint Neuro Inc.Trade Volume Report & Real-Time Stock Price Movement Reports - newser.com
Using data models to predict ClearPoint Neuro Inc. stock movementSell Signal & Daily Growth Stock Investment Tips - newser.com
Will ClearPoint Neuro Inc. stock outperform value stocksQuarterly Market Review & Real-Time Stock Price Movement Reports - newser.com
Will ClearPoint Neuro Inc. stock beat EPS estimatesQuarterly Market Review & Real-Time Stock Price Movement Reports - newser.com
Can ClearPoint Neuro’s (CLPT) New Robotic Platform Redefine Its Clinical Expansion Trajectory? - Sahm
ClearPoint Neuro (NASDAQ:CLPT) Reaches New 12-Month High – Here’s What Happened - Defense World
ClearPoint Neuro (CLPT): Gauging Valuation After Robotic Innovation, Insider Buying, and Huntington’s Therapy Progress - Yahoo Finance
Stifel maintains Clearpoint Neuro stock Buy rating, $17 target - MSN
ClearPoint Neuro (CLPT): Evaluating Valuation After Dr. Paul Larson Announced as Incoming Chief Medical Officer - Sahm
ClearPoint Neuro adds to gains, up 125% since Sept 23 - TradingView
ClearPoint Neuro (NASDAQ:CLPT) Hits New 52-Week HighHere's What Happened - MarketBeat
ClearPoint Neuro: AMT-130 Highlights A Bright Future (NASDAQ:CLPT) - Seeking Alpha
ClearPoint Neuro (NASDAQ:CLPT) Trading Up 5.9%Still a Buy? - MarketBeat
ClearPoint Neuro developing robotic navigation system for brain surgeries - Investing.com
ClearPoint Neuro developing robotic navigation system for brain surgeries By Investing.com - Investing.com Australia
ClearPoint Neuro : Announces Development and Demonstration of the Company's Proprietary Robotic Neuro-Navigation System - MarketScreener
ClearPoint Neuro Announces Development and Demonstration of the Company's Proprietary Robotic Neuro-Navigation System - ACCESS Newswire
Revolutionary Robot-Guided Brain Navigation System: ClearPoint Neuro's New Platform for Gene Therapy Delivery - Stock Titan
Clearpoint Neuro, Inc. Hits New 52-Week High of $22.38 - Markets Mojo
Full technical analysis of ClearPoint Neuro Inc. stockPortfolio Growth Summary & Free Risk Controlled Daily Trade Plans - newser.com
ClearPoint Neuro (NASDAQ:CLPT) Trading Down 4%What's Next? - MarketBeat
ClearPoint Neuro gains FDA clearance for software - MSN
Finanzdaten der Clearpoint Neuro Inc-Aktie (CLPT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Clearpoint Neuro Inc-Aktie (CLPT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Richards Timothy T. | Director |
Jun 10 '25 |
Sale |
13.28 |
10,000 |
132,800 |
77,381 |
| BURNETT JOSEPH | CEO and President |
Jun 09 '25 |
Sale |
13.29 |
21,247 |
282,373 |
243,522 |
1.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):